Inventor
Shumei Wang
Inventor
Foster City, CA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes24%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07CAcyclic or carbocyclic compounds2%
G02BOptical elements, systems or apparatus2%
G02FOptical devices or arrangements for the control of light by modification of the optical properties of the media of the elements involved therein2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,955,703Quantum-dot embedded polarizer component and display device using same202110,259,798High-purity magnesium lithospermate B and preparation method therefor201910,258,603Therapeutic compounds and uses thereof201910,202,378Therapeutic compounds and uses thereof201910,183,009Therapeutic compounds and uses thereof201910,150,767Therapeutic compounds and uses thereof20189,790,183'Pyridyl inhibitors of hedgehog signalling'20179,487,533'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20169,382,257'Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitors'20169,321,761'Pyridyl inhibitors of hedgehog signalling'20169,278,961'Pyridyl inhibitors of hedgehog signalling'20168,987,280'Pyrazolopyrimidine PI3K inhibitor compounds and methods of use'20158,809,331'Aminopyrimidine derivatives as LRRK2 modulators'20148,802,674'Aminopyrimidine derivatives as LRRK2 modulators'20148,653,098'Pyrazolopyridine PI3K inhibitor compounds and methods of use'20148,450,315'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20138,354,420'Aminopyrimidine derivatives as LRRK2 inhibitors'20138,158,626'Thiazolopyrimidine PI3K inhibitor compounds and methods of use'20127,893,059'Thiazolopyrimidine PI3K inhibitor compounds and methods of use'20117,888,364'Pyridyl inhibitors of hedgehog signalling'20117,846,929'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20107,678,913'Ureas as factor Xa inhibitors'20107,612,089'Tetrahydroisoquinolines as factor Xa inhibitors'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009Based in Foster, CA, US· patent location history
2010–2019Patents assigned to GENENTECH INC (19)· patent assignee history
2010–2017Based in Foster City, CA, US· patent location history
2011–2016Patents assigned to HOFFMANN LA ROCHE (5)· patent assignee history
2012–2016Patents assigned to WANG SHUMEI (7)· patent assignee history
2012–2016Patents assigned to SUTHERLIN DANIEL P (5)· patent assignee history
2012–2016Patents assigned to ZHU BING-YAN (5)· patent assignee history
2012–2019Based in South San Francisco, CA, US· patent location history
2019Based in Shanghai, CN· patent location history
2021Based in Hsinchu, TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 19 | 2010–2019 |
| WANG SHUMEIself | 7 | 2012–2016 |
| HOFFMANN LA ROCHE | 5 | 2011–2016 |
| SUTHERLIN DANIEL P | 5 | 2012–2016 |
| ZHU BING-YAN | 5 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Foster City, California, US | 13 | 2010–2017 |
| South San Francisco, California, US | 7 | 2012–2019 |
| Hsinchu, TW | 1 | 2021 |
| Shanghai, CN | 1 | 2019 |
| Foster, California, US | 1 | 2009 |